Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report

BMC Endocr Disord. 2016 May 3;16(1):20. doi: 10.1186/s12902-016-0099-5.

Abstract

Background: Type B insulin resistance is a rare autoimmune disease characterized by the presence of autoantibodies against the insulin receptor. Helicobacter pylori (H pylori) infection may play a causative role in the autoimmune diseases.

Case presentation: Here, we present a rare case of a 48-year old female patient, who had type B insulin resistance with systemic scleroderma and was successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection.

Conclusion: The present case suggests H pylori infection-related pathological mechanism may contribute to type B insulin resistance syndrome and autoimmune disorders. Treatment toward H pylori may be helpful to relieve syndrome of type B insulin resistance for H pylori positive patients.

Keywords: Helicobacter pylori infection; Systemic scleroderma; Type B insulin resistance.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / metabolism
  • Blood Glucose
  • Female
  • Helicobacter Infections / complications
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Insulin Resistance / immunology*
  • Middle Aged
  • Receptor, Insulin / immunology*

Substances

  • Anti-Bacterial Agents
  • Blood Glucose
  • Immunosuppressive Agents
  • Receptor, Insulin